HIV-1 antagonism of CD317/tetherin is species-specific and involves Vpu-mediated proteasomal degradation of the intrinsic immunity factor

Documenti analoghi

• Antagonism of CD317 Restriction of Human Immunodeficiency Virus Type 1 (HIV-1) Particle Release and Depletion of CD317 Are Separable Activities of HIV-1 Vpu
  di: Goffinet, Christine, et al.
  Pubblicazione: (2010)
• β-TrCP is dispensable for Vpu's ability to overcome the CD317/Tetherin-imposed restriction to HIV-1 release
  di: Tervo, Hanna-Mari, et al.
  Pubblicazione: (2011)
• HIV-1 Buds Predominantly at the Plasma Membrane of Primary Human Macrophages
  di: Welsch, Sonja, et al.
  Pubblicazione: (2007)
• CD317/Tetherin Is Enriched in the HIV-1 Envelope and Downregulated from the Plasma Membrane upon Virus Infection
  di: Habermann, Anja, et al.
  Pubblicazione: (2010)
• Endogenous CD317/Tetherin Limits Replication of HIV-1 and Murine Leukemia Virus in Rodent Cells and Is Resistant to Antagonists from Primate Viruses
  di: Goffinet, Christine, et al.
  Pubblicazione: (2010)